Calithera Biosciences Inc logo

Calithera Biosciences Inc

OTCPK:CALA (USA)  
$ 0.05 0 (0%) 11:08 PM EST
P/E:
At Loss
P/B:
0
Market Cap:
$ 244.00K
Enterprise V:
$ -1.20M
Volume:
16.04K
Avg Vol (2M):
18.80K
Also Trade In:
Volume:
16.04K
Market Cap $:
244.00K
PE Ratio:
At Loss
Avg Vol (2M):
18.80K
Enterprise Value $:
-1.20M
PB Ratio:
0

Business Description

Description
Calithera Biosciences Inc is a clinical-stage pharmaceutical company. The business activity of the firm functions through the region of the United States. It focuses on discovering and developing small molecule drugs directed against tumor and immune cell targets that control key metabolic pathways in the tumor microenvironment. Its product candidate is CB-839, an inhibitor of glutaminase for the treatment of solid tumors. Its other product candidate, CB-1158, is being developed for hematology and oncology indications.

Financial Strength

Name Current Vs Industry Vs History
Cash-To-Debt 15.28
Equity-to-Asset 0.71
Debt-to-Equity 0.08
Debt-to-EBITDA -0.04
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate 40.1
3-Year EPS without NRI Growth Rate 40.7
3-Year FCF Growth Rate 35.9

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 55.51
9-Day RSI 49.27
14-Day RSI 39.52
6-1 Month Momentum % -9.09
12-1 Month Momentum % -98.31

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 3.6
Quick Ratio 3.6
Cash Ratio 3.44

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -15.3
Shareholder Yield % 7.96

Profitability Rank

Name Current Vs Industry Vs History
ROE % -227.15
ROA % -87.6
ROIC % -950.09
ROC (Joel Greenblatt) % -1739.6
ROCE % -119.93

GF Value Rank

Name Current Vs Industry Vs History
EV-to-EBIT 0.03
EV-to-EBITDA 0.03
EV-to-FCF 0.03
Price-to-Net-Cash 0.01
Earnings Yield (Greenblatt) % 3333.33

Financials (Next Earnings Date:2023-11-09 Est.)

CALA's 30-Y Financials
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with OTCPK:CALA

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014

Calithera Biosciences Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -8.65
Beta -0.79
Volatility % 1737.62
14-Day RSI 39.52
14-Day ATR ($) 0.0077
20-Day SMA ($) 0.0499
12-1 Month Momentum % -98.31
52-Week Range ($) 0.01 - 3.6838
Shares Outstanding (Mil) 4.87

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Calithera Biosciences Inc Filings

Filing Date Document Date Form
No Filing Data

Calithera Biosciences Inc Stock Events

Event Date Price($)
No Event Data

Calithera Biosciences Inc Frequently Asked Questions

What is Calithera Biosciences Inc(CALA)'s stock price today?
The current price of CALA is $0.05. The 52 week high of CALA is $3.68 and 52 week low is $0.01.
When is next earnings date of Calithera Biosciences Inc(CALA)?
The next earnings date of Calithera Biosciences Inc(CALA) is 2023-11-09 Est..
Does Calithera Biosciences Inc(CALA) pay dividends? If so, how much?
Calithera Biosciences Inc(CALA) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1